内页大图
Home > News > News
DNA damage may re-regulate cancer gene regulatory mechanisms

DNA damage may re-regulate cancer gene regulatory mechanisms

Understanding the mechanisms that mediate extensive DNA damage in cancer genomes has always been the most interesting research area for cancer researchers...

2020-09-30
Combined immunotherapy can significantly improve the long-term survival of patients with melanoma

Combined immunotherapy can significantly improve the long-term survival of patients with melanoma

According to a study by the Royal MarsdenHS Foundation, the combination of two immunotherapeutics (ipilimumab and nivolumab) can prevent or reverse the progression of advanced melanoma within 5 years...

2020-09-30
Expected to develop new therapies for drug-resistant cancer cells

Expected to develop new therapies for drug-resistant cancer cells

In the latest research report published in the international journal Molecular Cell, scientists from Trinity College Dublin and other institutions have explored many new biological targets by studying and understanding the internal network of genes r...

2020-09-30
Clinical trials show that hematopoietic stem cell transplantation can reverse neuromyelitis optica

Clinical trials show that hematopoietic stem cell transplantation can reverse neuromyelitis optica

In a new clinical study, researchers at Northwestern University’s Fernberg School of Medicine and May York Clinic reported that hematopoietic stem cell transplantation can reverse a debilitating neurological disease called neuromyelitis optica (Neuro...

2020-09-30
iPSC-derived CAR-NK therapy has been clinically approved, which can solve the recurrence and cost challenges of CAR-T

iPSC-derived CAR-NK therapy has been clinically approved, which can solve the recurrence and cost challenges of CAR-T

Recently, Fate Therapeutics, which is committed to the development of cellular immunotherapy, announced that the US FDA has approved the investigational new drug (IND) application for its investigational therapy FT596...

2020-09-30
When tumor cells leave their original site and spread to other distant organs, most cancers are fatal (cancer metastasis)

When tumor cells leave their original site and spread to other distant organs, most cancers are fatal (cancer metastasis)

Target cells near tumor metastatic habitats are expected to develop new anti-cancer strategies...

2020-09-30
Reveal new secrets of NK cells and develop immunotherapy against cancer cells

Reveal new secrets of NK cells and develop immunotherapy against cancer cells

The natural killer (NK) cells of the immune system recognize and attack two main types of dangerous cells: virus-infected cells and cancer-affected cells...

2020-09-30
How to accurately target bladder cancer with common cold virus?

How to accurately target bladder cancer with common cold virus?

Non-muscle invasive bladder cancer is the tenth most common cancer in the UK and is difficult to treat. Current treatments are invasive and often have unpleasant side effects. The cancer also has a high recurrence rate-usually in a more aggressive fo...

2020-09-30
New lipid signaling targets may improve T cell immunotherapy

New lipid signaling targets may improve T cell immunotherapy

The immune system monitors our body, looking for things that do not belong to us, such as bacteria and viruses...

2020-09-30
Potential to use stem cells to treat myocardial infarction

Potential to use stem cells to treat myocardial infarction

As an emergency medical event caused by severe cardiovascular disease, myocardial infarction (MI) causes permanent life-threatening damage to the heart...

2020-09-30
By targeting the carrier protein E, it is expected to completely eliminate the hepatitis B virus in the human body

By targeting the carrier protein E, it is expected to completely eliminate the hepatitis B virus in the human body

Recently, scientists at the University of Alabama in the United States have discovered through research that human apolipoprotein E (apolipoprotein E) may promote hepatitis B virus infection and production...

2020-09-30
A variety of blood diseases can be reversed by CRISPR-Cas9 gene editing of specific hematopoietic stem cell subsets

A variety of blood diseases can be reversed by CRISPR-Cas9 gene editing of specific hematopoietic stem cell subsets

In a new study, researchers at research institutions such as the Fred Hutchinson Cancer Research Center in the United States used CRISPR-Cas9 genes to edit long-lived hematopoietic stem cells, causing problems such as sickle cell disease and β-anemia...

2020-09-30
Clinical trial of leukemia CAR-T cell therapy MB-102 (CD123 CAR T)

Clinical trial of leukemia CAR-T cell therapy MB-102 (CD123 CAR T)

MB-102 (CD123CART) is a CAR T cell therapy that can manipulate patients’ T cells to identify and eliminate CD123-expressing tumor cells...

2020-09-30
Cell \"cargo\" transporter can help repair damaged brain cells

Cell "cargo" transporter can help repair damaged brain cells

A report recently published by American researchers in the proceedings of the National Academy of Sciences pointed out that cellular \"cargo\" transporters-exosomes are not only essential for the development of brain neurons and neural circ...

2020-09-30
New CAR-T cells conquer fatal brain tumors

New CAR-T cells conquer fatal brain tumors

This immunotherapy called \"Chimeric Antigen Receptor T Cell Therapy\" (CAR-T) collects immune aggressive T cells from patients and genetically modifies them to identify specific tumors on the surface...

2020-09-30
How are immunotherapy drugs developed?

How are immunotherapy drugs developed?

Due to the high cost of anti-cancer drugs, it is difficult for public and private medical systems to provide patients with the latest treatment methods. If this trend continues, it will become increasingly difficult for patients to receive basic canc...

2020-09-30